The Role of Growth Hormone in Chronic Kidney Disease.
Semin Nephrol
; 41(2): 144-155, 2021 03.
Article
en En
| MEDLINE
| ID: mdl-34140093
ABSTRACT
Growth hormone (GH) has become a critical therapy for treating growth delay and failure in pediatric chronic kidney disease. Recombinant human GH treatment is safe and significantly improves height and height velocity in these growing patients and improved growth outcomes are associated with decreased morbidity and mortality as well as improved quality of life. However, the utility of recombinant human GH in adults with chronic kidney disease and end-stage renal disease for optimization of body habitus and reducing frailty remains uncertain. Semin Nephrol 41x-xx © 2021 Elsevier Inc. All rights reserved.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Hormona de Crecimiento Humana
/
Insuficiencia Renal Crónica
Límite:
Child
/
Humans
Idioma:
En
Revista:
Semin Nephrol
Año:
2021
Tipo del documento:
Article
País de afiliación:
Brasil